A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota

Zichen Luo,Weichen Xu,Ying Zhang,Liuqing Di,Jinjun Shan

DOI: https://doi.org/10.1016/j.phrs.2020.105088

IF: 10.334

2020-10-01

Pharmacological Research

Abstract:<p>Metabolic syndrome (MetS) is a series of symptoms including insulin resistance, obesity, dyslipidemia, elevated fasting blood glucose levels, and hepatic steatosis. As a key criterion in MetS, the onset of insulin resistance is related to abnormal levels of circulating free fatty acids and adipokines. It has been discovered in recent years that metabolites and pathogen-associated molecular patterns of intestinal/gut microbiota are also important factors that cause insulin resistance and MetS. Saponins are the main components of many botanicals and traditional Chinese medicines (TCMs), such as ginseng, platycodon, licorice, and alfalfa. They have poor bioavailability, but can be transformed into secondary glycosides and aglycones by intestinal microbiota, further being absorbed. Based on in vivo and in vitro data, we found that saponins and their secondary metabolites have a preventive effect on MetS, and the effective targets are distributed in the intestine and other organs in human body. Intestinal targets involve pancreatic lipase, dietary cholesterol, and intestinal microbiota. Other targets include central appetite, nuclear receptors such as PPAR and LXR, AMPK signaling pathway and adipokines levels, etc. In view of the poor bioavailability of saponins, it is inferred that targets for prototype-saponins to interfere with MetS is mainly located in the intestine, and the activation of other targets may be related to secondary glycosides and aglycones transformed from saponins by intestinal flora. We suggest that the role of intestinal microbiota in saponin intervention in MetS should be further investigated.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the intervention mechanisms of saponins on metabolic syndrome (MetS) and suggests further research on the role of the gut microbiota in this context. Specifically, the paper attempts to address the following issues:

1. **Etiology and Mechanisms of Metabolic Syndrome**:
- The paper provides a detailed introduction to the various symptoms of metabolic syndrome and their relationships with insulin resistance, obesity, dyslipidemia, etc.
- It particularly emphasizes the roles of free fatty acids (FFAs), adipokines, and the gut microbiota in insulin resistance.

2. **Potential Intervention Effects of Saponins**:
- The study finds that saponins, as major components of many plants and traditional Chinese medicines, may prevent metabolic syndrome through multiple pathways.
- These include mechanisms such as appetite suppression, inhibition of pancreatic lipase activity, regulation of nuclear receptors and signaling pathways to reduce energy intake, and improvement of insulin sensitivity.

3. **Role of the Gut Microbiota**:
- It highlights the importance of the gut microbiota in the pathogenesis of metabolic syndrome, especially in insulin resistance.
- It suggests that future research is needed to explore how the gut microbiota influences the intervention effects of saponins on metabolic syndrome.

In summary, this paper aims to synthesize existing in vivo and in vitro experimental data to elucidate the pathological mechanisms of metabolic syndrome and to explore the intervention mechanisms of saponins in metabolic syndrome, with a particular emphasis on the importance of the gut microbiota.